home / stock / tak / tak articles

TAK Articles, Takeda Pharmaceutical Company Limited American Depositary Shares - From 11/10/23

Stock Information
Company Name: Takeda Pharmaceutical Company Limited American Depositary Shares
Stock Symbol: TAK
Market: NYSE
Website: takeda.com
Menu
TAK TAK Quote TAK Short TAK News TAK Articles TAK Message Board
Get TAK Alerts

News, Short Squeeze, Breakout and More Instantly...
Why Is Neurocrine Biosciences Stock Trading Lower Today? | Benzinga

Thursday, Neurocrine Biosciences Inc (NASDAQ: NBIX) released Phase 2 study results from two signal-seeking pipeline programs in...
Back To Back FDA Approval For Takeda Within Two Days, Secures Green Signal For Rare Blood Disorder Therapy | Benzinga

The FDA approved Takeda Pharmaceutical Co Ltd's (NYSE: TAK) Adzynma, a recombinant (genetically engineered) protein product indi...

Takeda's Crohn's Disease Fistulas Candidates Fall Short In Mid-Stage Study, Settles Tax Dispute With Irish Revenue Commissioners | Benzinga

Takeda Pharmaceutical Co Ltd (NYSE: TAK) released topline data from the Phase 3 ADMIRE-CD II study, assessing Alofisel (darvadstrocel) for com...

A Look Into Takeda Pharmaceutical Inc's Price Over Earnings | Benzinga

Looking into the current session, Takeda Pharmaceutical Inc. (NYSE:TAK) shares are trading at $14.63, after a 2.14% drop. Over the past month, the ...
'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories | Benzinga

Benzinga Microsoft's Nadella Criticizes Google's Exclusive Content Deals Amid Antitrust Case In a significant development, Microsoft ...

Takeda Withdraws Lung Cancer Drug From US After Failed Confirmatory Trial | Benzinga

Following discussions with the FDA, Takeda Pharmaceutical Co Ltd (NYSE: TAK) will voluntarily withdraw Exkivity (mobocertinib) ...

Morphic Therapeutic's Stock Plunges On Monday - Here's Why? | Benzinga

Since Friday, Morphic Therapeutic (NASDAQ: MORF) shares have plunged from $47.92 to $26.25 after the company announced the publication of...
Top 4 Health Care Stocks That Should Keep You Up At Night | Benzinga

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indic...

Is This 250-Year-Old Japanese Big Pharma Giant Selling For Half Price Right Now? | Benzinga

When it comes to Big Pharma, Japan’s Takeda Pharmaceutical Co Ltd (NYSE: TAK) is a conservative play that could prove to be a big winner give...

Ovarian Cancer Player ImmunoGen Can Potentially Be Attractive M&A Target: JP Morgan | Benzinga

JP Morgan upgraded ImmunoGen Inc (NASDAQ: IMGN) from Neutral to Overweight with a price target of $22, up from $9, based on insights...
Previous 10 Next 10